News Hub | News Direct

Technology

Artificial Intelligence Big Data Cloud Computing Cyber Security Data Management Electronics Enterprise & Network Technology Financial Technology Hardware Mobile & Wireless Nanotechnology Semiconductor Software Telecommunications
Article thumbnail News Release

Startup Reduces Sugar In Natural Beverages Without Spoiling The Taste; Juice, Dairy Industries Could Be Ripe For BlueTree Technologies

OurCrowd

by Jeremy Ruden More than half of the global population – 51%, or over 4 billion people – will be obese by 2035, according to a 2023 report from the World Obesity Atlas. One of the major causes of obesity is sugar. While candy and carbonated drinks might be on many people’s radars as a primary source of sugar, natural beverages such as orange juice are also packed with it. With these health concerns in mind, scientists at startup BlueTree Technologies created proprietary technology that removes up to 50 percent of the sugar from juice and other natural beverages. BlueTree’s innovative method selectively removes a specific sugar molecule, preserving the beverages’ natural taste and health benefits. The company is now raising a funding round through OurCrowd, the global equity investment platform. “Our technology targets the disaccharides in the juice without harming the other ingredients,” says Yossi Sefi, BlueTree’s Chief Technical Officer. “It is capable of locating the exact kind of sugar in orange juice, for example, and removing it without harming the pulp, the vitamin C, the amino acids, or any other important ingredients.” In tests, half of those surveyed reported they preferred the flavor of orange juice with less sugar – while noticing no difference in the aroma and texture from the original. Successful Pilot The company, which was nurtured at the Fresh Start FoodTech incubator in northern Israel established by OurCrowd with Tnuva, Tempo and Finistere Ventures, has successfully adapted its technology for commercial applications. “We developed a turnkey platform that can be easily integrated into any manufacturing line,” says Michael Gordon, BlueTree’s CEO, who was formerly a senior director at Coca-Cola before joining the company. Gordon oversaw BlueTree’s first major deployment at a plant belonging to Priniv, one of the top three natural juice manufacturers in Israel. “It took us no more than two months to fully integrate our system and we did it without interfering with the plant’s overall operations,” Gordon says. BlueTree built all the equipment and the machinery for the Priniv installation in-house. The facility can now produce some 10,000 liters of orange juice daily, with up to 50% less sugar. BlueTree is poised for full-scale commercial production, with patents secured in the EU and Brazil, while awaiting approval from the Israeli Ministry of Health and the U.S. Food and Drug Administration. International beverage manufacturers and distributors, working to produce healthier products and avoid warning labels or progressive taxes on sugary drinks, are also showing a great deal of interest in BlueTree’s platform. The company signed an agreement with a leading international manufacturer, which it hopes will result in revenues of at least $6 million a year. It is also in advanced negotiations with other global producers in Italy and Spain and major juice manufacturers in Brazil and Thailand. One Platform The dairy industry is another target for BlueTree’s technology. Working together with a major local food manufacturer, the company produced a prototype that reduced the sugar in skimmed milk by some 75%. Commercialization plans are underway. The company also began an R&D project for beer with an international beverage manufacturer. The agreement forecasts the production of more than 200 million liters of reduced-sugar beer a year. “We can make the world better by reducing the sugar from all of nature’s liquids for all consumers,” Gordon says. “Our versatile tech could help curb the obesity crisis by cutting two teaspoons of sugar from children’s daily diet.” For more information about investing in BlueTree via OurCrowd, click HERE. Featured photo courtesy of BlueTree Technologies. OurCrowd was started in 2013, driven by the idea that the business of building startups grows bigger and better when the global ‘crowd’ gains access to VC-level investment opportunities.Today, OurCrowd is a global venture and alternative investing platform that empowers institutions and individuals to invest and engage in emerging companies. OurCrowd vets and selects companies, invests its capital, and provides its global network with unparalleled access to co-invest and contribute connections, talent and deal flow. OurCrowd builds value for its portfolio companies throughout their lifecycles, providing mentorship, recruiting industry advisors, navigating follow-on rounds and creating growth opportunities through its network of multinational partnerships. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Lisa Graston lisa.graston@ourcrowd.com Company Website http://www.ourcrowd.com

February 07, 2024 08:15 AM Eastern Standard Time

Image
Article thumbnail News Release

Duetto Acquires Micerate; a Dynamic Pricing and Booking Engine for Meetings and Events

Duetto

Duetto, a global leader in revenue management systems, proudly unveils the successful acquisition of Micerate, a leading provider of dynamic pricing and online booking tools tailored for meetings and event spaces. This strategic milestone underscores Duetto's unwavering dedication to dynamic revenue management solutions, with a heightened focus on the groups and events sector, solidifying its position as an industry leader adept at meeting the diverse needs of the hospitality landscape. Founded in Germany, Micerate brings a wealth of expertise, dedicated to delivering specialized solutions that elevate meeting space profitability and streamline booking efficiency for its valued clients. Key features of the Micerate platform: Strategic Revenue Optimization Dynamic pricing of event spaces empowers hoteliers to strategically map pricing and control capacities for hotel event and meeting space. The algorithm-based pricing isn't just about numbers; it's a sustainable boost to event and meeting space sales, ensuring Duetto customers stay ahead in a competitive market. Effortless Sales Empowerment Revolutionize the meeting and event space quoting process with an intuitive quote generator, making the creation of quotes and function sheets easier. Hoteliers can engage customers dynamically during the quote creation process, creating not just transactions, but meaningful connections that drive conversions. Tailored Online Event Sales Experience Hoteliers can elevate their online presence with a personalized meeting and event space booking engine, seamlessly integrated onto their brand site. This personalized tool not only maximizes event revenue but also champions efficiency, a dual focus that underscores Duetto's commitment across its entire product suite. Investment in revenue technology has continued to grow year on year with the 2024 Duetto annual trends and predictions report showing again that hotel technology spending continues to increase. 71.4% of those surveyed predict that hotel technology spend will continue to increase over the next three years, with the key focuses being on price automation and group optimization. In a triumphant year marked by resilience and growth, Duetto experienced robust expansion across key markets, with a noteworthy highlight being record-breaking growth in the Asia Pacific region. Duetto's unwavering commitment to innovation and providing cutting-edge solutions has solidified its position as a preferred partner for hotels and casinos worldwide, adding 200,000 hotel rooms to the platform in 2023 alone. Quotes: “Duetto is built on innovation, constantly staying ahead of the market to ensure our customers maintain a consistent competitive advantage. The addition of Micerate to our platform is incredibly important as it aligns seamlessly with our vision. Beyond dynamically pricing groups and events for increased revenue, Micerate introduces a sophisticated booking engine directly integrated into the hotel's brand site, streamlining operations and saving valuable time for meetings and event teams. Our customers seek three essential elements from Duetto: enhanced revenue generation, precise forecasting, and operational efficiencies – Micerate delivers on all fronts.” David Woolenberg, CEO, Duetto “This acquisition represents another milestone for Duetto, positioning us for continued growth in our sector. Our robust financial position, marked by steady revenue growth, profitability, and a strong balance sheet, provides us with a platform for sustained success in an ever-evolving market. This strategic move not only contributes to our inorganic growth but also underscores our confidence and capability to pursue further opportunities.” Vishal Save, CFO, Duetto “Micerate brings exceptional capabilities in managing and booking function space to the Duetto family. It complements and expands Duetto BlockBuster to comprehensively deliver a solution for groups, meetings, and events. Together, Duetto and Micerate empower sales and revenue teams with an unparalleled suite of tools, enhancing revenue and efficiency. This strategic integration enables the workflow collaboration, analytics, and visibility to drive alignment and execution between the Sales and Revenue Management functions for our customers while highlighting Duetto's deep commitment to delivering innovative best-in-class solutions for group management.” Darren Koch, CPO, Duetto “As someone who has dedicated their entire career to hospitality, this collaboration with Duetto marks an exciting next step. Joining forces with a global player that aligns with our values of ease-of-use and exceptional customer service is not just a strategic move; it's a testament to our shared vision for the industry. I am genuinely excited about the possibilities ahead, as we continue our journey of innovation and dedication to maximizing revenue for hotels.” Gerhard Wasem, Micerate About Duetto Duetto delivers a suite of SaaS cloud-native applications for hospitality businesses to optimize every booking opportunity for greater revenue impact. The unique combination of hospitality experience and technology leadership drives Duetto to look for innovative solutions to industry challenges. The software as a service platform allows hotels, casinos, and resorts to leverage real-time dynamic data sources and actionable insights into pricing and demand across the enterprise. More than 4,000 hotel and casino resort properties in more than 60 countries have partnered to use Duetto’s applications, which include GameChanger for pricing, ScoreBoard for intelligent reporting, and BlockBuster for contracted-business optimization. Duetto was named the world's #1 revenue management system in 2022, 2023, and 2024 in the HotelTechAwards. For more information, please visit https://www.duettocloud.com/ About Micerate Selling function spaces and banquet rooms more innovatively with efficient, revenue-optimized sales processes. Contact Details Katrina Wheeler katrina.wheeler@duettoresearch.com Company Website https://www.duettocloud.com/en-us/

February 07, 2024 08:08 AM Eastern Standard Time

Article thumbnail News Release

Duetto Acquires Micerate; a Dynamic Pricing and Booking Engine for Meetings and Events

Duetto

Duetto, a global leader in revenue management systems, proudly unveils the successful acquisition of Micerate, a leading provider of dynamic pricing and online booking tools tailored for meetings and event spaces. This strategic milestone underscores Duetto's unwavering dedication to dynamic revenue management solutions, with a heightened focus on the groups and events sector, solidifying its position as an industry leader adept at meeting the diverse needs of the hospitality landscape. Founded in Germany, Micerate brings a wealth of expertise, dedicated to delivering specialized solutions that elevate meeting space profitability and streamline booking efficiency for its valued clients. Key features of the Micerate platform: Strategic Revenue Optimization Dynamic pricing of event spaces empowers hoteliers to strategically map pricing and control capacities for hotel event and meeting space. The algorithm-based pricing isn't just about numbers; it's a sustainable boost to event and meeting space sales, ensuring Duetto customers stay ahead in a competitive market. Effortless Sales Empowerment Revolutionize the meeting and event space quoting process with an intuitive quote generator, making the creation of quotes and function sheets easier. Hoteliers can engage customers dynamically during the quote creation process, creating not just transactions, but meaningful connections that drive conversions. Tailored Online Event Sales Experience Hoteliers can elevate their online presence with a personalized meeting and event space booking engine, seamlessly integrated onto their brand site. This personalized tool not only maximizes event revenue but also champions efficiency, a dual focus that underscores Duetto's commitment across its entire product suite. Investment in revenue technology has continued to grow year on year with the 2024 Duetto annual trends and predictions report showing again that hotel technology spending continues to increase. 71.4% of those surveyed predict that hotel technology spend will continue to increase over the next three years, with the key focuses being on price automation and group optimization. In a triumphant year marked by resilience and growth, Duetto experienced robust expansion across key markets, with a noteworthy highlight being record-breaking growth in the Asia Pacific region. Duetto's unwavering commitment to innovation and providing cutting-edge solutions has solidified its position as a preferred partner for hotels and casinos worldwide, adding 200,000 hotel rooms to the platform in 2023 alone. Quotes: “Duetto is built on innovation, constantly staying ahead of the market to ensure our customers maintain a consistent competitive advantage. The addition of Micerate to our platform is incredibly important as it aligns seamlessly with our vision. Beyond dynamically pricing groups and events for increased revenue, Micerate introduces a sophisticated booking engine directly integrated into the hotel's brand site, streamlining operations and saving valuable time for meetings and event teams. Our customers seek three essential elements from Duetto: enhanced revenue generation, precise forecasting, and operational efficiencies – Micerate delivers on all fronts.” David Woolenberg, CEO, Duetto “This acquisition represents another milestone for Duetto, positioning us for continued growth in our sector. Our robust financial position, marked by steady revenue growth, profitability, and a strong balance sheet, provides us with a platform for sustained success in an ever-evolving market. This strategic move not only contributes to our inorganic growth but also underscores our confidence and capability to pursue further opportunities.” Vishal Save, CFO, Duetto “Micerate brings exceptional capabilities in managing and booking function space to the Duetto family. It complements and expands Duetto BlockBuster to comprehensively deliver a solution for groups, meetings, and events. Together, Duetto and Micerate empower sales and revenue teams with an unparalleled suite of tools, enhancing revenue and efficiency. This strategic integration enables the workflow collaboration, analytics, and visibility to drive alignment and execution between the Sales and Revenue Management functions for our customers while highlighting Duetto's deep commitment to delivering innovative best-in-class solutions for group management.” Darren Koch, CPO, Duetto “As someone who has dedicated their entire career to hospitality, this collaboration with Duetto marks an exciting next step. Joining forces with a global player that aligns with our values of ease-of-use and exceptional customer service is not just a strategic move; it's a testament to our shared vision for the industry. I am genuinely excited about the possibilities ahead, as we continue our journey of innovation and dedication to maximizing revenue for hotels.” Gerhard Wasem, Micerate About Duetto Duetto delivers a suite of SaaS cloud-native applications for hospitality businesses to optimize every booking opportunity for greater revenue impact. The unique combination of hospitality experience and technology leadership drives Duetto to look for innovative solutions to industry challenges. The software as a service platform allows hotels, casinos, and resorts to leverage real-time dynamic data sources and actionable insights into pricing and demand across the enterprise. More than 4,000 hotel and casino resort properties in more than 60 countries have partnered to use Duetto’s applications, which include GameChanger for pricing, ScoreBoard for intelligent reporting, and BlockBuster for contracted-business optimization. Duetto was named the world's #1 revenue management system in 2022, 2023, and 2024 in the HotelTechAwards. For more information, please visit https://www.duettocloud.com/ About Micerate Selling function spaces and banquet rooms more innovatively with efficient, revenue-optimized sales processes. Contact Details Katrina Wheeler katrina.wheeler@duettoresearch.com Company Website https://www.duettocloud.com/en-us/

February 07, 2024 07:53 AM Eastern Standard Time

Image
Article thumbnail News Release

Primer Selected for the 2024 GSV Cup 50

Spark Metro PR

Primer has been named to the 2024 GSV Cup 50 out of 1,000 nominations of pre-seed and seed-stage companies. The GSV Cup, presented by Google Cloud and GSV Ventures, and supported by HolonIQ, recognizes the world's most innovative digital learning and workforce skills startups. The GSV Cup 50 will be featured at the 15th Annual ASU+GSV Summit, the preeminent global gathering for “Pre-K to Gray” education leaders, in San Diego, CA. The GSV Cup 50 highlights the most promising startups that support learners across the Pre-K to Gray spectrum, distributed across early childhood education, K-12, higher education, workforce learning, and adult consumer learning. All nominees were evaluated against GSV’s “Five P’s” framework: People, Product, Potential, Predictability, and Purpose. "Being chosen for the GSV Cup 50 is a great honor, highlighting our alignment with GSV's values and our commitment to innovation in digital learning,” said Mark Naufel, Founder of Primer. “Being part of this elite group starts a new chapter for Primer, as we continue to revolutionize the idea of a lifelong adaptive learning experience powered by an AI personal companion." “This year’s GSV Cup was both incredibly competitive and incredibly inspiring,” said Deborah Quazzo, Managing Partner of GSV Ventures and Co-founder of the ASU+GSV Summit. “The GSV Cup 50 are undoubtedly the stars of tomorrow. With almost 80% of the companies focused on leveraging AI, they’ve got both eyes on the future of education – not just what we can see now, but what we can build beyond view. We’re so excited to see the transformative effects of these companies over the next five, ten, even fifteen years.” The 2024 GSV Cup 50 companies are poised to make a global impact, with 34% headquartered outside of the United States and representation from 15 unique countries. This year’s GSV Cup 50 also represent a variety of diverse perspectives and experiences, with 66% of the companies led by female or BIPOC founder(s). The GSV Cup 50 join a prestigious group of past Cup startups, including Ello, Ethena, LingoAce, Prenda, Stride, TransfrVR, and TeachFX. See Primer and all of the companies selected to the GSV Cup 50 at https://www.asugsvsummit.com/gsv-cup. About Primer Primer is an AI personal companion poised to revolutionize the digital learning landscape, with the market expected to reach heights of $370 billion by 2026. Leveraging a patent-pending, generative AI system, Primer offers tailored, engaging experiences that enhance both learning and daily life. Beyond traditional education, Primer learns and grows with each user, continuously evolving to meet their personal needs. It’s this seamless ability to customize learning for everyone, from inquisitive schoolchildren to professionals advancing their careers, that underscores Primer’s dedication to ensuring no one navigates through life without a worldclass advocate. About ASU+GSV Summit Now celebrating its 15th year, the ASU+GSV Summit has become the world's most important and impactful gathering of leaders across "Pre-K to Gray" education and workforce learning. Hosted in San Diego, the annual event attracts over 7,000 in-person and 10,000 virtual registrants. Past GSV keynote speakers and honorees have included Presidents George Bush, Barack Obama and Vicente Fox Quesada, Former Secretaries of Education Arne Duncan and John King, Surgeon General Vivek Murthy, Gina Raimondo, Reed Hastings, John Legend, Condoleezza Rice, Justice Sandra Day O'Connor, Priscilla Chan, Laurene Powell Jobs, and more. ### For Media Relations contact: Mark Naufel,, info@primer.net Contact Details Primer Mark Naufel +1 302-597-6768 info@primer.net Company Website https://primer.net/

February 07, 2024 12:10 AM Eastern Standard Time

Image
Article thumbnail News Release

MultiversX Blockchain Data Now Embedded in Global Internet Data Streams via Google BigQuery

STORM Partners

Sibiu, Romania, February 06, 2023 - MultiversX, the leader in sharding technology across public distributed networks, has now become available on Google BigQuery. This marks a significant milestone, and opens access to blockchain data in an easy manner, with Google embedding data streams from the MultiversX blockchain into the internet and making it readily available. Google BigQuery is an enterprise-grade, petabyte-scale cloud data warehouse, with a cost-effective pay-as-you-go pricing model. Anyone with a Google Account can now get insights about the MultiversX network, such as the top 100 block producers, without running specialized software and waiting to sync the ledger. Other quick-to-use sample queries available directly on the MultiversX dataset page are: details about the latest blocks, daily transaction count, largest EGLD transfers in a specific timeframe or top used smart contracts. MultiversX network on-chain data on BigQuery: https://console.cloud.google.com/marketplace/product/bigquery-public-data/blockchain-analytics-multiversx-mainnet-eu Developers and projects using MultiversX for conducting and recording actions on-chain are now granted access to an important new instrument for their toolkit. With the help of Google BigQuery, they can perform in-depth product analysis to understand their users’ behavior, and evaluate what their product development priorities are. “ Analyzing and interpreting data to reveal useful insights and information about product usage is a science barely explored compared to its potential utility for the web3 space. Having Google resolve a big part of the hassle for MultiversX projects is an important step towards making dApps better, more useful, and more appealing to the masses. “ said Lucian Mincu, MultiversX Foundation CIO. The service is provided through the MultiversX ETL, a tool developed by the core team of the Layer 1 smart contract platform, which extracts, transforms and feeds Google BigQuery with blockchain data at hourly intervals. Google Cloud involvement in the MultiversX ecosystem extends beyond this important integration. The two leading technology companies are co-working on multiple initiatives to accelerate Web3, including a startup accelerator program, hackathons and developer initiatives, and joint business developments, such as the presence of MultiversX as partner in the Google Cloud booth at GITEX Global, Dubai 2023. About MultiversX MultiversX is a highly scalable public blockchain via sharding, decentralized through 3200 validator nodes, built to solve the three fundamental problems critical for widespread, global adoption: transition from dial-up to broadband, significant UX paradigm shift, and simplicity of self-custody. About Google BigQuery Google BigQuery is a Google Cloud Platform service that serves as a cloud-based and scalable enterprise data warehouse for rapid SQL queries and interactive analysis of massive datasets. The solution is known for its quick processing time and large data capabilities. Distributed by STORM Partners. Contact Adrian Bono for interviews and quotes - adrian.bono@storm.partners or telegram @STORMPartners Contact Details MultiversX Media Contact Dan Voicu, Head of Communications dan.voicu@multiversx.com

February 06, 2024 12:02 PM Eastern Standard Time

Image
Article thumbnail News Release

Wormhole Foundation Awards Contributor Grant to Zpoken to Advance Trustless ZK Transfers for NEAR and Ethereum

Wormhole Foundation

The Wormhole Foundation, a research and development organization dedicated to interoperability between blockchains, is excited to announce a Contributor Grant to the team at Zpoken. The addition of the Zpoken team to Wormhole’s decentralized set of contributors is a major step forward for Wormhole's platform in the context of trustless verification of cross-chain messages using Zero Knowledge (ZK) technology. Zpoken has established itself as a key player in the field of ZK technology globally, notably with its work on the NEAR ZK Light Client. Wormhole’s capabilities will include the first trustless, zero knowledge Ethereum-to-NEAR corridor. This bi-directional bridge will enable all major NEAR and Ethereum-based assets to be transferred across chains without needing to trust any centralized actors for message verification, despite Wormhole currently having the most trusted set of decentralized validators ( see Uniswap’s Bridge Assessment ), the Wormhole Guardians. Given Wormhole’s modular and flexible technology stack, Wormhole Guardians will continue to verify messages for any corridor not yet integrated with ZK proofs. Robinson Burkey, Co-founder and Chief Commercial Officer at Wormhole Foundation, remarked, "Offering our developer community trustless verification for their messages between Ethereum and NEAR will be a major milestone. The Foundation is very excited to add Zpoken to the decentralized team of collaborators and the integration of their ZK technology into Wormhole's interoperability platform, and we look forward to rolling this technology out to developers." Mike Yezhov, CEO at Zpoken added, “Integrating cryptographic commitments into economic models to enhance the interoperability of the decentralized web is an incredibly exciting endeavor. We are thrilled to contribute our expertise in NEAR Zero-Knowledge light clients to some of the largest and most promising interoperability protocols within the Web3 ecosystem. This contribution represents a significant step forward in securing and streamlining the interaction between diverse blockchain networks, thereby unlocking new possibilities for decentralized applications and services.” For further inquiries and collaboration opportunities, please contact the Wormhole Foundation at hello@wormhole.foundation. About Zpoken Zpoken is a full-stack Web3 development organization that specializes in the development and implementation of ZK technology, cryptography solutions and decentralized tech. Their work on the Near ZK Light Client is instrumental in advancing the field of trustless cross-chain communication, offering a new paradigm of privacy and security in blockchain technology. About Wormhole Foundation The Wormhole Foundation is the steward of Wormhole - the world’s first generalized messaging protocol. Our mission is to empower passionate people in the research and development of blockchain interoperability technologies. Through grants, research, and ecosystem programs, we seek to enable teams to build secure, open-source, and decentralized products within the Wormhole ecosystem. If you’re interested in helping achieve our mission, follow us on Twitter or contact us at hello@wormhole.foundation. Contact Details Ditto PR Wahaj Khan +1 630-935-7684 wahaj@dittopr.co

February 06, 2024 09:02 AM Eastern Standard Time

Article thumbnail News Release

Doceree Secures Patent for its Groundbreaking Technology Empowering Marketers to Elevate Patient-Physician Engagement Through Real-Time Triggers on EHR Platforms

Doceree

Doceree, the leading global healthcare marketing platform building unprecedented solutions for programmatic HCP marketing using proprietary data tools, today announced the grant of a patent by US Patent and Trademark Office (USPTO) for its distinguished feature ‘Triggers’ that uses clinical data as real-time prompts for messaging to HCPs on Electronic Health Record Platforms, in a HIPAA-compliant and privacy-forward way. In the United States, physicians possess the potential to enhance healthcare delivery by leveraging relevant information; however, the challenge lies in the timely accessibility of crucial data. Despite the ongoing digital transformation in the healthcare sector, Healthcare Professionals (HCPs) continue to face a notable gap in accessing up-to-date information, a resource that is currently exclusive to life sciences organizations. As the industry undergoes rapid digitization, the need for efficient information dissemination to empower healthcare providers becomes increasingly evident. Bridging this information gap, Doceree introduced Triggers- a technological solution designed to guarantee the delivery of optimal and well-informed care to patients. Doceree's groundbreaking patent, officially paves the way for the integration of Doceree Triggers into the pharmaceutical marketing landscape. This patent encompasses a sophisticated medical product processing system that employs a first graphical user interface connected to an Electronic Health Record (EHR) platform. The system is designed to display messages in real-time to medical providers, tailored to their patients' predefined conditions. These conditions are inputted into the patient's electronic health record during the interaction between the patient and the healthcare provider, encompassing crucial details such as definitions of international classifications of diseases (ICD) codes. This patent not only represents a pivotal achievement, affirming Doceree's pioneering strategy in revolutionizing the interaction between pharmaceutical marketing and healthcare professionals, but it also plays a crucial role in aiding Electronic Health Record (EHR) platforms. The patent ensures real-time clinical data mapping in a HIPAA-compliant manner, contributing to the optimization of EHRs for health data interoperability. This optimization holds significant importance in supporting clinical research efforts. The seamless integration of research and clinical care within a health system has the potential to boost clinical trial participation rates, enhance health outcomes, reduce the cost of care, and foster greater patient satisfaction. " This patent not only signifies our steadfast dedication to pushing the boundaries and creating pioneering solutions for addressing the industry's most intricate challenges but also stands as a significant milestone in our journey towards establishing leadership in healthcare innovation and technology," stated Harshit Jain MD, Founder, and Global CEO of Doceree. " Beyond its legal implications, this inaugural patent reflects the resilience and forward-thinking ethos that defines our company. It serves as the bedrock for sustained success in the ever-evolving landscape of innovation, embodying our commitment to continuous advancement. The issuance of this patent is a powerful reminder of what can be achieved through collaborative efforts and a shared dedication to our strategic objectives," he emphasized. Doceree Triggers stands out by offering pharmaceutical manufacturers a distinctive set of capabilities. It enables the strategic planning and coordination of healthcare provider and direct-to-consumer campaigns, leveraging comprehensive insights into patient and provider behaviors, including the evaluation of past and present script performance. The platform empowers users to activate media seamlessly across various channels, encompassing display, video, and connected TV, all while optimizing bids to enhance overall business outcomes. Real-time performance measurement is a key feature, providing immediate insights into each campaign's effectiveness. Moreover, Doceree Triggers facilitates the dynamic optimization of ongoing campaigns by automatically adjusting parameters, enhancing audience quality, boosting script lift, and maximizing overall media efficiency. This multifaceted approach ensures that pharmaceutical marketing efforts are not only well-informed but also agile and responsive, driving impactful results in the competitive landscape. About Doceree: Doceree is a global platform building unprecedented solutions for healthcare professional (HCP) messaging with proprietary data and advanced tools. Utilizing an extensive global network of digital endemic and point-of-care platforms, Doceree facilitates seamless and meaningful communication between life sciences brands and HCPs, ensuring delivery of highly personalized messages to HCPs at scale. To learn more, https://doceree.com/us/doceree-triggers/. Contact Details Doceree Priyanka Bhasin +91 78387 03702 priyanka.bhasin@doceree.com Doceree Tanya Singh +91 70420 89805 tanya.singh@doceree.com Company Website https://doceree.com/us/doceree-triggers/

February 06, 2024 09:00 AM Eastern Standard Time

Article thumbnail News Release

Sick of Cold Calling? Emotionally Intelligent AI Could Help You Break Into The $325.7 Billion Market Opportunity Of MarTech

Benzinga

By Faith Ashmore, Benzinga Interested in investing in HiveSkill’s campaign? Click here to get started. The proliferation of social media platforms, the rise of mobile devices and the advancements in technology have made digital marketing the new norm. While print advertising is still far from being phased out, ad spending is increasingly being devoted to digital marketing. However, not all digital marketing is created equal, and it can be easy to get lost in the crowd. That’s why companies like HiveSkill that harness the power of AI are so integral in the next generation of marketing. HiveSkill offers a unique marketing solution characterized by customization, hyper-targeting and a foundation of trust and data. Its approach involves delivering context-driven marketing campaigns tailored to pre-qualified leads sourced from its industry-leading consumer database. Powered by advanced artificial intelligence, HiveSkill conducts thorough audience profiling, categorizing contacts into relevant interest groups or "buckets." This enables them to create the optimal audience for effectively conveying a company's story and messages. HiveSkill is successfully deploying competencies in multiple large industries while differentiating itself from the big tech companies like Meta (NASDAQ: META), Google (NASDAQ: GOOG), and Amazon (NASDAQ: AMZN). The global digital marketing software industry was valued at $49.4 billion in 2019 and is forecasted to grow at a CAGR of 17.4% from 2020 to 2027. The global marketing technology (MarTech) market was valued at $325.7 billion in 2022 and is expected to grow at a CAGR of 19.8% from 2023 to 2030. Not to mention, in 2021, the market for artificial intelligence in marketing was estimated at $15.84 billion, and it is projected to increase to more than $107.5 billion by 2028. HiveSkill seems to be firmly positioning itself at the nexus of all these growing industry segments. HiveSkill differentiates itself from competitors by harnessing the power of emotionally intelligent AI. Through its construction of a comprehensive database, utilizing entrepreneurial networks and strategic partnerships with Crunchbase and Hubspot, HiveSkill instills greater confidence in companies' marketing strategies. In a marketing landscape dominated by big tech alternatives, where businesses can often feel like insignificant drops in an overwhelming ocean, HiveSkill aims to provide the opposite experience. When businesses choose to collaborate with HiveSkill, they not only gain access to an extensive existing database and tools, but HiveSkill will also use existing infrastructure and leads to help build a unique “Hive” of engaged prospects, fostering a mutually beneficial feedback loop of data. Consequently, HiveSkill's database has transformed into a robust engine comprising millions of carefully curated and profiled contacts. This empowers them to effectively engage and connect with their desired target audiences, including "look-alike" segments. HiveSkill takes the guesswork out of chasing leads, which is why the company boasts the tagline of “All you need to do is close the deal.” Firmly positioned in highly lucrative markets, the company could be the next step in the evolution of digital marketing. The company is currently hosting an investment offering with a minimum investment of only $0.25. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

February 06, 2024 08:20 AM Eastern Standard Time

Article thumbnail News Release

CytoReason’s AI-Driven Disease Model Platform Trusted By 5 Top 10 Pharma Companies Harnesses Big Data To Speed Drug Discovery And Development

OurCrowd

By Meg Flippin, Benzinga Click here to learn more about CytoReason and how to invest through OurCrowd. Big data is transforming everything from the way we drive to the way we shop or even the way we consume energy. But when it comes to healthcare and fighting diseases, it still takes 10 or more years to bring a drug or treatment to market. What’s more, 90% of drugs in development fail. A big reason is that all the disparate data being collected from doctors, hospitals, clinical trials and patient outcomes reside in silos – thus not functioning together, and that only seems poised to get worse. The volume of human molecular data is growing rapidly, but analytic capabilities aren’t keeping up. That is essentially slowing progress in finding potential cures and more effective treatments. To overcome this challenge, a platform that can digest, organize and make sense of all the different data types and sources is needed – and that’s where CytoReason and its Disease Model Platform come in. Founded in 2016 to address this problem, CytoReason created what the company says is the first AI model to map treatments, patient groups and disease mechanisms while constantly evolving and learning. Bringing It All Together Researchers of all levels can rely on CytoReason’s proprietary data and innovative technology to make data-driven decisions across the drug development life cycle. Scientists can identify potential targets, prioritize indications, and stratify patient populations. Program leaders can compare drugs across multiple diseases or multiple drugs within a single disease. C-level executives can gain valuable tools to manage and optimize entire drug portfolios. Never before has there been that much data organized and analyzed on one platform, says CytoReason. Similar to how navigation apps provide layers of data about streets, buildings and addresses, CytoReason's Disease Model Platform offers layers of pre-computed data, which can include results from clinical trials, data on proteins and single-cell data. With multiple models for various diseases, users of the platform can identify potential targets, prioritize treatments, stratify patients and find possible drug combinations. User-generated data can also be integrated, and hypotheses across different treatments can be tested. The platform learns with you and can help you understand the cause of the disease and identify potential R&D avenues for prevention. Giving Pharma An Edge For drug development companies and researchers, CytoReason says the biggest advantage of its Disease Model Platform is its ability to compare assets across different diseases. With a single standard for all disease models, users can answer critical questions including which patients may benefit most from the drug, what other diseases the drug can be developed for, and how the drug stacks up against the drugs currently available. By answering those questions, decision-makers in pharma and biotech companies can find new opportunities, increase success rates and shorten the drug development cycle. Sounds too good to be true? The platform is already being used by five of the top ten pharma companies including Sanofi SA (NASDAQ: SNY), Pfizer Inc. (NYSE: PFE). Sanofi, which tapped CytoReason’s AI platform for use in the field of inflammatory bowel disease (IBD) expanded its multiyear collaboration last year. Sanofi is using the platform to identify patient subtypes and pair them with IBD targets. Under the terms of the expanded agreement, Sanofi will pay CytoReason an undisclosed multimillion-dollar amount. Pfizer, which has been working with CytoReason since 2019, also extended its collaboration, announcing in 2022 that it committed a $20 million equity investment, has options to license CytoReason’s platform and disease models and fund supplementary project support in a deal potentially worth up to $110 million over the next five years. Since the two began collaborating, Pfizer has used CytoReason's biological models in its research to enhance the understanding of the immune system as it develops innovative drugs for immune-mediated and immuno-oncology diseases. CytoReason's platform has provided Pfizer with multiple insights in its research and development programs across over 20 diseases. CytoReason’s platform has also benefited Poolbeg Pharma, which has been using it to find novel approaches for treating influenza. Poolbeg’s disease progression data from influenza human challenge trials combined with CytoReason’s disease model platform led to the discovery of multiple novel drug targets for the treatment of influenza. Big data is growing exponentially, particularly in the healthcare field, but getting it under one roof has proven difficult. It's the reason it takes so long to develop drugs and why the majority of them fail. Platforms like CytoReason are working to change that, providing AI-generated insights to understand disease mechanisms and disease progression, as well as potential treatment methods. In a world where data is endless, CytoReason is making sense of it all. To learn more about CytoReason and its novel approach to data click here. OurCrowd was started in 2013, driven by the idea that the business of building startups grows bigger and better when the global ‘crowd’ gains access to VC-level investment opportunities.Today, OurCrowd is a global venture and alternative investing platform that empowers institutions and individuals to invest and engage in emerging companies. OurCrowd vets and selects companies, invests its capital, and provides its global network with unparalleled access to co-invest and contribute connections, talent and deal flow. OurCrowd builds value for its portfolio companies throughout their lifecycles, providing mentorship, recruiting industry advisors, navigating follow-on rounds and creating growth opportunities through its network of multinational partnerships. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Lisa Graston lisa.graston@ourcrowd.com Company Website http://www.ourcrowd.com

February 06, 2024 08:10 AM Eastern Standard Time

1 ... 111112113114115 ... 627